In vivo, EP could prevent the tumor growth and extend the survival of large B-cell lymphoma (DLBCL) mice model by downregulating the expression of HMGB1 and phosphorylation of ERK1/2 and Src [48]. This evidence concerns the gene HMGB1 and diffuse large B-cell lymphoma.